---
figid: PMC9684170__fimmu-13-1016730-g003
figtitle: Hypersensitivity reactions to small molecule drugs
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9684170
filename: fimmu-13-1016730-g003.jpg
figlink: /pmc/articles/PMC9684170/figure/f3/
number: F3
caption: The mechanisms involved in non-allergic hypersensitivity reactions to small
  molecule drugs. (A) Direct activation of mast cells. (B) Activation of complement.
  (C) Inhibition of cyclooxygenases. (D) Elevation of bradykinin. (E) Activation of
  the RhoA/ROCK signaling pathway. ER, endoplasmic reticulum; MRGPRX2, Mas-related
  G protein-coupled receptor X2; PLCγ, phospholipase C gamma; IP3, inositol triphosphate;
  IP3R, inositol triphosphate receptor; PKC, protein kinase C; P38, p38(MAPK) pathway;
  MAC, membrane attack complex; 12-/15-/5-HETEs, 12-/15-/5-hydroxy eicosatetraenoic
  acids; 12-/15-/5-HPETE, 12-/15-/5-hydroperoxyeicosatetraenoic acid; LTA4/LTB4/LTC4/LTD4/LTE4,
  leukotriene A4/B4/C4/D4/E4; PGG2/PGI2/PGE2/PGE2a/PGD2, prostaglandin G2/I2/E2/E2a/D2;
  TXA2, thromboxane A2; BKR-2, bradykinin receptor type 2; JAK, Janus-activated kinase;
  STAT3, signal transducer and activator of transcription 3; DAG, diacylglycerol;
  eNOS, endothelial nitric oxide synthase; NO, nitric oxide; PLA2, phospholipase A2;
  PGs, prostaglandins; LTs, leukotrienes; GDP-Rho A, an inactive GDP-bound Ras homolog
  family member A; GTP-Rho A, an active GTP-bound Ras homolog family member A; ROCK,
  Rho-associated kinase; MLC, myosin light chain; p-MLC, phospho-myosin light chain;
  MLCP, myosin light chain phosphatase.
papertitle: Hypersensitivity reactions to small molecule drugs.
reftext: Jiayin Han, et al. Front Immunol. 2022;13:1016730.
year: '2022'
doi: 10.3389/fimmu.2022.1016730
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: drug hypersensitivity reactions | small molecule drugs | allergic drug hypersensitivity
  reactions | non-allergic drug hypersensitivity reactions | screening hypersensitivity
  reactions in clinical practice | hypersensitivity evaluation for investigational
  new drugs or post-marketing drugs
automl_pathway: 0.8633581
figid_alias: PMC9684170__F3
figtype: Figure
redirect_from: /figures/PMC9684170__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9684170__fimmu-13-1016730-g003.html
  '@type': Dataset
  description: The mechanisms involved in non-allergic hypersensitivity reactions
    to small molecule drugs. (A) Direct activation of mast cells. (B) Activation of
    complement. (C) Inhibition of cyclooxygenases. (D) Elevation of bradykinin. (E)
    Activation of the RhoA/ROCK signaling pathway. ER, endoplasmic reticulum; MRGPRX2,
    Mas-related G protein-coupled receptor X2; PLCγ, phospholipase C gamma; IP3, inositol
    triphosphate; IP3R, inositol triphosphate receptor; PKC, protein kinase C; P38,
    p38(MAPK) pathway; MAC, membrane attack complex; 12-/15-/5-HETEs, 12-/15-/5-hydroxy
    eicosatetraenoic acids; 12-/15-/5-HPETE, 12-/15-/5-hydroperoxyeicosatetraenoic
    acid; LTA4/LTB4/LTC4/LTD4/LTE4, leukotriene A4/B4/C4/D4/E4; PGG2/PGI2/PGE2/PGE2a/PGD2,
    prostaglandin G2/I2/E2/E2a/D2; TXA2, thromboxane A2; BKR-2, bradykinin receptor
    type 2; JAK, Janus-activated kinase; STAT3, signal transducer and activator of
    transcription 3; DAG, diacylglycerol; eNOS, endothelial nitric oxide synthase;
    NO, nitric oxide; PLA2, phospholipase A2; PGs, prostaglandins; LTs, leukotrienes;
    GDP-Rho A, an inactive GDP-bound Ras homolog family member A; GTP-Rho A, an active
    GTP-bound Ras homolog family member A; ROCK, Rho-associated kinase; MLC, myosin
    light chain; p-MLC, phospho-myosin light chain; MLCP, myosin light chain phosphatase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SPACA9
  - SPG21
  - C3
  - C1QA
  - C1QB
  - CD40LG
  - MBL2
  - MBL3P
  - C1R
  - C1S
  - C2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - STAT3
  - C4B
  - TPSAB1
  - TPSB2
  - TPSD1
  - TPSG1
  - BDKRB2
  - PLCG1
  - PLCG2
  - MRGPRX2
  - ROCK1
  - ROCK2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - GPR162
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - KLK4
  - ERVK-2
  - ERVK-3
  - NOS3
  - ENO4
  - CS
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - C5
  - C5AR1
  - C6
  - C7
  - C9
  - C8A
  - C8B
  - C8G
  - MLC1
  - LAMB3
  - PTGDS
  - HPGDS
  - AP1S2
  - 12-HETE
  - 15-HETE
  - histamine
  - C3(H2O)Bb
  - Bradykinin
  - 5-HPETE
  - 5-HETE
  - Arachidonic acid
  - Ca2+
  - GDP
  - PGE2
---
